Home ยป “Seladelpar Reduces Interleukin-31 and Bile Acids in PBC Patients, Explaining Its Anti-Pruritic Effects”

“Seladelpar Reduces Interleukin-31 and Bile Acids in PBC Patients, Explaining Its Anti-Pruritic Effects”

by satcit

https://pubmed.ncbi.nlm.nih.gov/38117036

Seladelpar, a PPAR-delta agonist, reduces interleukin-31 and bile acids in PBC patients, potentially explaining its anti-pruritic effects.

You may also like

Leave a Comment